Strategic Advisors
|
Deborah Ancona, PhD Seley Distinguished Professor of Management; Professor of Organization Studies; Faculty Director, MIT Leadership Center, MIT Sloan School of Management |
Retsef Levi, PhD J. Spencer Standish (1945) Professor of Management; Associate Professor of Operations Management, MIT Sloan School of Management |
|
Denny A. Ausiello, MD CATCH Co-Founder, Director; Jackson Professor of Clinical Medicine, Harvard Medical School; Chief of Medicine, MGH; Director, Pfizer |
Andrew Lo, PhD Charles E. and Susan T. Harris Professor of Finance; Director, Laboratory for Financial Engineering, MIT Sloan School of Management |
|
Ernest Berndt, PhD, MS Louis E Seley Professor of Applied Economics, Sloan School of Management; Co-director Biomedical Enterprise Program |
Alex 'Sandy' Pentland, PhD Professor of Media Arts and Sciences, Toshiba Professor, MIT Media Lab; Director, MIT Media Lab Entrepreneurship Program |
|
Charles L. Cooney, PhD Robert T. Haslam Professor of Chemical Engineering, MIT; Faculty Director, Deshpande Center for Technological Innovation |
Ram Sasisekharan, PhD Director, Harvard – MIT Health Sciences and Technology, Edward Hood Taplin Professor of Health Sciences & Technology and Biological Engineering, MIT |
|
Michael A. Cusumano, PhD Sloan Management Review Distinguished Professor of Management, MIT Sloan School of Management |
Phillip A. Sharp, PhD Institute Professor, Koch Institute for Integrative Cancer Research, MIT |
|
Elazer Edelman, MD, PhD, FACC Thomas D & Virginia W Cabot Professor of HST, Health Sciences and Technology Program, MIT |
Anthony Sinskey, ScD Faculty Director, CBI; Professor of Biology and Health Sciences and Technology, MIT |
Executive Committee
The Executive Committee for NEWDIGS is an advisory body, which meets once a quarter throughout the calendar year. The role of the Executive Committee is to contribute ideas for projects, vet new opportunities, and disseminate emerging insights and recommendations from NEWDIGS activities The Executive Committee will assist with outreach to potential sponsors and endorse the goals of NEWDIGS projects as well the alignment of new projects with NEWDIGS mission and priorities; It has no financial or fiduciary responsibility, nor does it make any product-specific decisions. Typical agenda items include research updates, workshop opportunities, new mini-consortia proposals and pending publications.
|
Elizabeth Cobbs, PhD Head, Medical Policy & Quality Research Merck & Co. Inc. |
Hilary M. Malone, PhD Chief Regulatory Officer, Head of Global Regulatory Affairs Sanofi |
|
Nick Crabb, PhD Program Director, Scientific Affairs National Institute for Health & Clinical Excellence (NICE) |
Kenneth A. Oye, PhD Associate Professor of Political Science and Engineering Systems;; Co-Director, MIT Program on Emerging Technologies Massachusetts Institute of Technology |
|
Anne-Virginie Eggimann, MSc Vice President, Regulatory Science bluebird bio |
Peter Saltonsall President and CEO National Organization for Rare Disorders (NORD) |
|
Hans-Georg Eichler, MD, MSc Senior Medical Officer European Medicines Agency |
Mark Trusheim, MSc Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Management Massachusetts Institute of Technology; President, Co-Bio Consulting |
|
Gigi Hirsch, M.D. Executive Director, Center for Biomedical Innovation, Massachusetts Institute of Technology; Director NEWDIGS |
Affiliated Faculty and Researchers
|
Jane F. Barlow, MD, MPH, MBA Research Affiliate, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project; CEO, Jane Barlow & Associates |
Kenneth A. Oye, PhD Associate Professor of Political Science and Engineering Systems;; Co-Director, MIT Program on Emerging Technologies Massachusetts Institute of Technology |
|
Ernest Berndt, PhD, MS Louis E Seley Professor of Applied Economics, Sloan School of Management; Co-director Biomedical Enterprise Program |
Nitin R. Patel, PhD Research Affiliate, MIT Center for Biomedical Innovation; Founder, Chairman, and Chief Technology Officer, Cytel Statistical Software and Services |
|
Jeff Brown, PhD Assistant Professor, Department of Population Medicine, Harvard Medical School |
Casey Quinn, PhD Research Affiliate, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project |
|
Chester Drum, MD, PhD Assistant Professor, Department of Medicine, National University of Singapore |
G.K. Raju, PhD CBI Distinguished Fellow; Chairman, CBI Biomanufacturing Steering Committee; Executive Director, MIT Pharmaceutical Manufacturing Initiative |
|
R. John Glasspool Senior Advisor, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project |
J. Russell Teagarden, DMH, MA Senior Health Care Practitioner, Independent Advisor, Researcher and Writer; Financing and Reimbursement of Cures in the US (FoCUS) Project |
|
Donald Han, BSc Pharm Research Affiliate, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project |
Mark Trusheim, MSc Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Management Massachusetts Institute of Technology; President, Co-Bio Consulting |
|
Judy Maro, PhD, MS Research Affiliate, Center for Biomedical Innovation, Research Fellow in the Department of Population Medicine at Harvard Medical School and the Harvard Pilgrim Health Care Institute |
NEWDIGS Staff
|
David P. Fritsche, MBA dpfritsc@mit.edu Technology Officer, Learning Ecosystems Accelerator for Patient-centered & Sustainable (LEAPS) Innovation Project 617-324-7763 |
Eric A. Small easmall@mit.edu Administrative Assistant II, NEWDIGS; Assistant to Executive Director Gigi Hirsch 617-324-4841 |
|
Gigi Hirsch, M.D. ghirsch@mit.edu Executive Director, Center for Biomedical Innovation, Massachusetts Institute of Technology; Director NEWDIGS 617-253-9609 |
Katie Torrence ktorrenc@mit.edu Project Coordinator, Financing and Reimbursement of Cures in the US (FoCUS) 617-324-2695 |
|
Kay Larholt, ScD klarholt@mit.edu Director of Integrated Knowledge Solutions 617-253-7333 |
Mark Trusheim, MSc trusheim@mit.edu Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Management Massachusetts Institute of Technology; President, Co-Bio Consulting |
|
Daniel Mytelka, PhD, MBA, CFA mytelka@mit.edu Director, Simulation & Policy Research, Financing and Reimbursement of Cures in the US (FoCUS) |
Deborah L. Young, EMBA, Ed.M. debyoung@mit.edu Director of Operations, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project 617-324-7756 |
|
Kelly Necastro, MPH kneca@mit.edu Project Coordinator, Learning Ecosystems Accelerator for Patient-centered & Sustainable (LEAPS) Innovation Project 617-324-7763 |
Colin Young, PhD colyoung@mit.edu Director, Drug Development Pipeline Research, Financing and Reimbursement of Cures in the US (FoCUS) 617-324-7261 |
FoCUS Project Team
Financing and Reimbursement of Cures in the U.S.
|
Jane F. Barlow, MD, MPH, MBA
Research Affiliate, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project; CEO, Jane Barlow & Associates |
J. Russell Teagarden, DMH, MA
Senior Health Care Practitioner, Independent Advisor, Researcher and Writer; Financing and Reimbursement of Cures in the US (FoCUS) Project |
|
R. John Glasspool
Senior Advisor, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project |
Katie Torrence
Project Coordinator, Financing and Reimbursement of Cures in the US (FoCUS) 617-324-2695 |
|
Donald Han, BSc Pharm
Research Affiliate, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project |
Mark Trusheim, MSc
Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Management Massachusetts Institute of Technology; President, Co-Bio Consulting |
|
Gigi Hirsch, M.D.
Executive Director, Center for Biomedical Innovation, Massachusetts Institute of Technology; Director NEWDIGS 617-253-9609 |
Deborah L. Young, EMBA, Ed.M.
Director of Operations, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project 617-324-7756 |
|
Daniel Mytelka, PhD, MBA, CFA
Director, Simulation & Policy Research, Financing and Reimbursement of Cures in the US (FoCUS) |
Colin Young, PhD
Director, Drug Development Pipeline Research, Financing and Reimbursement of Cures in the US (FoCUS) 617-324-7261 |
|
Casey Quinn, PhD
Research Affiliate, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project |
LEAPS Project Team
|
David P. Fritsche, MBA
Technology Officer, Learning Ecosystems Accelerator for Patient-centered & Sustainable (LEAPS) Innovation Project 617-324-7763 |
Kelly Necastro, MPH
Project Coordinator, Learning Ecosystems Accelerator for Patient-centered & Sustainable (LEAPS) Innovation Project 617-324-7763 |
|
Gigi Hirsch, M.D.
Executive Director, Center for Biomedical Innovation, Massachusetts Institute of Technology; Director NEWDIGS 617-253-9609 |
Mark Trusheim, MSc
Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Management Massachusetts Institute of Technology; President, Co-Bio Consulting |
|
Kay Larholt, ScD
Director of Integrated Knowledge Solutions 617-253-7333 |
Strategic Advisory Network
|
Anna D. Barker, PhD Co-Director, Complex Adaptive Systems (CAS); Director, National Biomarker Development Alliance (NBDA); Professor, School of Life Sciences, Arizona State University (ASU) |
Secretary Marylou Sudders, MS, Hon.DSc Secretary of Health and Human Services, Commonwealth of Massachusetts |
|
Alex 'Sandy' Pentland, PhD Professor of Media Arts and Sciences, Toshiba Professor, MIT Media Lab; Director, MIT Media Lab Entrepreneurship Program |
Susan Windham-Bannister, PhD President & CEO, Biomedical Growth Strategies LLC; Managing Partner, Biomedical Innovation Advisors LLC |
|
Michael S. Sherman, MD, MBA, MS, CPE Senior Vice President & Chief Medical Officer; Harvard Pilgrim Health Care |
Janet Woodcock, MD Director, Center for Drug Evaluation and Research, US Food and Drug Administration |
